The EMMES Company

The Emmes Company LLC (Rockville, Maryland), is a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation. In partnership with leading researchers, Emmes’ expertise in infectious diseases, vaccines, ophthalmology, oncology, neurology, substance abuse use disorders and maternal and child health, tackles human health challenges throughout the world. The Emmes team of >1,000 experienced professionals provide the full range of CRO expertise necessary to conduct >2000+ clinical studies over >40 years with offices throughout the US, Europe, Canada, and India.

Emmes provides experience in planning, implementing, and managing multicenter clinical trials in a variety of areas, including hematopoietic cell transplantation, cellular therapy, and rare diseases, statistical design and analysis, clinical trial design and management, complex data collection system design and implementation, site monitoring, safety reporting, and regulatory support. Emmes staff develop BMT CTN MOPs, study protocols, and statistical designs, establish operational and analytical methodology, coordinate study activities, analyzing data, preparing administrative, recruitment, technical, and statistical reports for meetings and coordinating Network communications.

Key Contacts

Adam Mendizabal, PhD

  • Co-Principal Investigator for the DCC of the BMT CTN
  • Vice President, Emmes
  • Director, Transplant, Allergy, Autoimmune Research Unit, Emmes